Release Date: 18/01/21 16:18 Summary: Remedial Action Taken in Respect of ASX Listing Rule 10.11 Price Sensitive: No Download Document 213.06KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status